Management of sympathetic ophthalmia with the fluocinolone acetonide implant.

Authors:

V.B. Mahajan; K.M. Gehrs; D.A. Goldstein; D.H. Fischer; J.S. Lopez; J.C. Folk

Publication date:

2009-03

We examined whether implantation of the fluocinolone acetonide (Retisert) implant achieved control of inflammation and a reduced need for oral corticosteroids or immunosuppressives in patients with sympathetic ophthalmia (SO).

Citation:

Mahajan VB, Gehrs KM, Goldstein DA, Fischer DH, Lopez JS, Folk JC. "Management of sympathetic ophthalmia with the fluocinolone acetonide implant." Ophthalmology. 2009;116(3):552-557.e1.

Year of Publication:

2009